nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—CYP11A1—polycystic ovary syndrome	0.428	0.587	CbGaD
Mitotane—SHBG—polycystic ovary syndrome	0.301	0.413	CbGaD
Mitotane—FDX1—ovarian follicle—polycystic ovary syndrome	0.0313	0.288	CbGeAlD
Mitotane—CYP11A1—corpus luteum—polycystic ovary syndrome	0.0182	0.167	CbGeAlD
Mitotane—CYP11A1—ovarian follicle—polycystic ovary syndrome	0.0142	0.131	CbGeAlD
Mitotane—FDX1—adrenal cortex—polycystic ovary syndrome	0.00347	0.0319	CbGeAlD
Mitotane—FDX1—endometrium—polycystic ovary syndrome	0.0031	0.0285	CbGeAlD
Mitotane—FDX1—pituitary gland—polycystic ovary syndrome	0.0028	0.0258	CbGeAlD
Mitotane—FDX1—adipose tissue—polycystic ovary syndrome	0.00279	0.0257	CbGeAlD
Mitotane—CYP11B1—adrenal cortex—polycystic ovary syndrome	0.00277	0.0255	CbGeAlD
Mitotane—FDX1—adrenal gland—polycystic ovary syndrome	0.0025	0.0231	CbGeAlD
Mitotane—FDX1—female gonad—polycystic ovary syndrome	0.00234	0.0215	CbGeAlD
Mitotane—FDX1—vagina—polycystic ovary syndrome	0.00232	0.0214	CbGeAlD
Mitotane—FDX1—endocrine gland—polycystic ovary syndrome	0.00217	0.02	CbGeAlD
Mitotane—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.00204	0.0994	CcSEcCtD
Mitotane—CYP11B1—adrenal gland—polycystic ovary syndrome	0.002	0.0184	CbGeAlD
Mitotane—CYP11B1—endocrine gland—polycystic ovary syndrome	0.00174	0.016	CbGeAlD
Mitotane—CYP11A1—adrenal cortex—polycystic ovary syndrome	0.00158	0.0145	CbGeAlD
Mitotane—Econazole—CYP17A1—polycystic ovary syndrome	0.00151	0.663	CrCbGaD
Mitotane—Fungal infection—Metformin—polycystic ovary syndrome	0.00139	0.0677	CcSEcCtD
Mitotane—CYP11A1—adipose tissue—polycystic ovary syndrome	0.00127	0.0117	CbGeAlD
Mitotane—SERPINA6—pituitary gland—polycystic ovary syndrome	0.00121	0.0112	CbGeAlD
Mitotane—CYP11A1—adrenal gland—polycystic ovary syndrome	0.00114	0.0105	CbGeAlD
Mitotane—SHBG—endometrium—polycystic ovary syndrome	0.00113	0.0104	CbGeAlD
Mitotane—SERPINA6—adrenal gland—polycystic ovary syndrome	0.00108	0.00997	CbGeAlD
Mitotane—CYP11A1—female gonad—polycystic ovary syndrome	0.00106	0.00977	CbGeAlD
Mitotane—SHBG—uterus—polycystic ovary syndrome	0.00104	0.00957	CbGeAlD
Mitotane—SHBG—pituitary gland—polycystic ovary syndrome	0.00102	0.0094	CbGeAlD
Mitotane—SHBG—adipose tissue—polycystic ovary syndrome	0.00102	0.00936	CbGeAlD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000993	0.00713	CbGpPWpGaD
Mitotane—CYP11A1—endocrine gland—polycystic ovary syndrome	0.000987	0.00909	CbGeAlD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.000982	0.00705	CbGpPWpGaD
Mitotane—FDX1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.000963	0.00691	CbGpPWpGaD
Mitotane—CYP11B1—Endogenous sterols—CYP17A1—polycystic ovary syndrome	0.000962	0.00691	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—HSD3B1—polycystic ovary syndrome	0.000943	0.00677	CbGpPWpGaD
Mitotane—SERPINA6—endocrine gland—polycystic ovary syndrome	0.000938	0.00864	CbGeAlD
Mitotane—SHBG—adrenal gland—polycystic ovary syndrome	0.000912	0.0084	CbGeAlD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—LHB—polycystic ovary syndrome	0.00086	0.00617	CbGpPWpGaD
Mitotane—SHBG—female gonad—polycystic ovary syndrome	0.00085	0.00783	CbGeAlD
Mitotane—Injury—Metformin—polycystic ovary syndrome	0.000849	0.0413	CcSEcCtD
Mitotane—SHBG—vagina—polycystic ovary syndrome	0.000845	0.00778	CbGeAlD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.00084	0.00603	CbGpPWpGaD
Mitotane—CYP11A1—Endogenous sterols—CYP17A1—polycystic ovary syndrome	0.000823	0.00591	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000805	0.00578	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.0008	0.00574	CbGpPWpGaD
Mitotane—Lethargy—Metformin—polycystic ovary syndrome	0.000796	0.0387	CcSEcCtD
Mitotane—SHBG—endocrine gland—polycystic ovary syndrome	0.000791	0.00728	CbGeAlD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.000776	0.00557	CbGpPWpGaD
Mitotane—Econazole—CYP19A1—polycystic ovary syndrome	0.000769	0.337	CrCbGaD
Mitotane—CYP11B1—Endogenous sterols—CYP19A1—polycystic ovary syndrome	0.000762	0.00547	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.000721	0.00517	CbGpPWpGaD
Mitotane—Breast disorder—Metformin—polycystic ovary syndrome	0.000705	0.0343	CcSEcCtD
Mitotane—FDX1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000656	0.00471	CbGpPWpGaD
Mitotane—CYP11A1—Endogenous sterols—CYP19A1—polycystic ovary syndrome	0.000652	0.00468	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000649	0.00466	CbGpPWpGaD
Mitotane—Neutropenia—Metformin—polycystic ovary syndrome	0.000631	0.0307	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000623	0.00447	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.000617	0.00443	CbGpPWpGaD
Mitotane—Drowsiness—Metformin—polycystic ovary syndrome	0.000601	0.0292	CcSEcCtD
Mitotane—Infestation NOS—Metformin—polycystic ovary syndrome	0.000601	0.0292	CcSEcCtD
Mitotane—Infestation—Metformin—polycystic ovary syndrome	0.000601	0.0292	CcSEcCtD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000597	0.00428	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000581	0.00417	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—STAR—polycystic ovary syndrome	0.000571	0.0041	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—CYP19A1—polycystic ovary syndrome	0.000571	0.0041	CbGpPWpGaD
Mitotane—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000569	0.0277	CcSEcCtD
Mitotane—FDX1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00054	0.00388	CbGpPWpGaD
Mitotane—Hepatitis—Metformin—polycystic ovary syndrome	0.00054	0.0262	CcSEcCtD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.000535	0.00384	CbGpPWpGaD
Mitotane—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000531	0.0258	CcSEcCtD
Mitotane—Eye disorder—Metformin—polycystic ovary syndrome	0.000505	0.0245	CcSEcCtD
Mitotane—Flushing—Metformin—polycystic ovary syndrome	0.000501	0.0244	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000492	0.00353	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000492	0.00353	CbGpPWpGaD
Mitotane—Angiopathy—Metformin—polycystic ovary syndrome	0.00049	0.0238	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—STAR—polycystic ovary syndrome	0.000488	0.0035	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—CYP19A1—polycystic ovary syndrome	0.000488	0.0035	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—HSD3B1—polycystic ovary syndrome	0.000485	0.00348	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000484	0.00347	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000481	0.00345	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000474	0.0034	CbGpPWpGaD
Mitotane—Malnutrition—Metformin—polycystic ovary syndrome	0.00047	0.0228	CcSEcCtD
Mitotane—Dysgeusia—Metformin—polycystic ovary syndrome	0.00046	0.0224	CcSEcCtD
Mitotane—CYP11B1—Endogenous sterols—POMC—polycystic ovary syndrome	0.000458	0.00329	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00045	0.00323	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000447	0.00321	CbGpPWpGaD
Mitotane—Vision blurred—Metformin—polycystic ovary syndrome	0.000443	0.0215	CcSEcCtD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000441	0.00317	CbGpPWpGaD
Mitotane—Tremor—Metformin—polycystic ovary syndrome	0.00044	0.0214	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—HSD3B2—polycystic ovary syndrome	0.000433	0.0031	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000428	0.00307	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—HSD3B1—polycystic ovary syndrome	0.000415	0.00298	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000412	0.00296	CbGpPWpGaD
Mitotane—Hypertension—Metformin—polycystic ovary syndrome	0.000406	0.0197	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000397	0.0193	CcSEcCtD
Mitotane—CYP11A1—Endogenous sterols—POMC—polycystic ovary syndrome	0.000392	0.00281	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000391	0.00281	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00039	0.0028	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—SULT2A1—polycystic ovary syndrome	0.000386	0.00277	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000385	0.00276	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000382	0.00274	CbGpPWpGaD
Mitotane—Infection—Metformin—polycystic ovary syndrome	0.000381	0.0185	CcSEcCtD
Mitotane—Shock—Metformin—polycystic ovary syndrome	0.000377	0.0183	CcSEcCtD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000377	0.00271	CbGpPWpGaD
Mitotane—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000376	0.0183	CcSEcCtD
Mitotane—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000376	0.0183	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000373	0.00268	CbGpPWpGaD
Mitotane—Skin disorder—Metformin—polycystic ovary syndrome	0.000373	0.0181	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—HSD3B2—polycystic ovary syndrome	0.00037	0.00266	CbGpPWpGaD
Mitotane—Anorexia—Metformin—polycystic ovary syndrome	0.000366	0.0178	CcSEcCtD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000362	0.0026	CbGpPWpGaD
Mitotane—Hypotension—Metformin—polycystic ovary syndrome	0.000358	0.0174	CcSEcCtD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000354	0.00254	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000349	0.00251	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000345	0.00247	CbGpPWpGaD
Mitotane—Paraesthesia—Metformin—polycystic ovary syndrome	0.000344	0.0167	CcSEcCtD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.000343	0.00246	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CYP11A1—polycystic ovary syndrome	0.000342	0.00245	CbGpPWpGaD
Mitotane—Somnolence—Metformin—polycystic ovary syndrome	0.000341	0.0166	CcSEcCtD
Mitotane—Dyspepsia—Metformin—polycystic ovary syndrome	0.000338	0.0164	CcSEcCtD
Mitotane—Decreased appetite—Metformin—polycystic ovary syndrome	0.000333	0.0162	CcSEcCtD
Mitotane—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000331	0.0161	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—SULT2A1—polycystic ovary syndrome	0.00033	0.00237	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000317	0.00228	CbGpPWpGaD
Mitotane—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000316	0.0154	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00031	0.00222	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000303	0.00218	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000303	0.00217	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000299	0.00214	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.000293	0.00211	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000289	0.00208	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000287	0.00206	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000285	0.00205	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000283	0.00203	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000281	0.00202	CbGpPWpGaD
Mitotane—FDX1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000277	0.00199	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SUOX—polycystic ovary syndrome	0.000277	0.00199	CbGpPWpGaD
Mitotane—Asthenia—Metformin—polycystic ovary syndrome	0.000275	0.0134	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000274	0.00196	CbGpPWpGaD
Mitotane—Diarrhoea—Metformin—polycystic ovary syndrome	0.000262	0.0128	CcSEcCtD
Mitotane—FDX1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000258	0.00185	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—POMC—polycystic ovary syndrome	0.000257	0.00184	CbGpPWpGaD
Mitotane—Dizziness—Metformin—polycystic ovary syndrome	0.000254	0.0123	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000252	0.00181	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00025	0.0018	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000245	0.00176	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000244	0.00175	CbGpPWpGaD
Mitotane—Vomiting—Metformin—polycystic ovary syndrome	0.000244	0.0119	CcSEcCtD
Mitotane—Rash—Metformin—polycystic ovary syndrome	0.000242	0.0118	CcSEcCtD
Mitotane—Dermatitis—Metformin—polycystic ovary syndrome	0.000242	0.0117	CcSEcCtD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000241	0.00173	CbGpPWpGaD
Mitotane—Headache—Metformin—polycystic ovary syndrome	0.00024	0.0117	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000235	0.00169	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000234	0.00168	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000231	0.00166	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000231	0.00165	CbGpPWpGaD
Mitotane—Nausea—Metformin—polycystic ovary syndrome	0.000228	0.0111	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—GNAS—polycystic ovary syndrome	0.000224	0.00161	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000223	0.0016	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000222	0.00159	CbGpPWpGaD
Mitotane—FDX1—Metabolism—TEAD2—polycystic ovary syndrome	0.000219	0.00157	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000219	0.00157	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—IL18—polycystic ovary syndrome	0.000214	0.00154	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000214	0.00154	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000213	0.00153	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000211	0.00151	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000207	0.00149	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000207	0.00149	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000204	0.00147	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.0002	0.00143	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000198	0.00142	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000197	0.00142	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000193	0.00138	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000192	0.00138	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—GNAS—polycystic ovary syndrome	0.000192	0.00138	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00019	0.00136	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00019	0.00136	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000184	0.00132	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—IL18—polycystic ovary syndrome	0.000183	0.00132	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000182	0.00131	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000175	0.00126	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000175	0.00126	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000174	0.00125	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000172	0.00124	CbGpPWpGaD
Mitotane—FDX1—Metabolism—STAR—polycystic ovary syndrome	0.000166	0.00119	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000165	0.00118	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000165	0.00118	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000164	0.00118	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000162	0.00117	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000152	0.00109	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—POMC—polycystic ovary syndrome	0.000151	0.00108	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00015	0.00108	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00015	0.00108	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00015	0.00108	CbGpPWpGaD
Mitotane—FDX1—Metabolism—HMMR—polycystic ovary syndrome	0.000148	0.00106	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000147	0.00106	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000147	0.00105	CbGpPWpGaD
Mitotane—FDX1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000141	0.00101	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00014	0.001	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000139	0.001	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000133	0.000954	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000132	0.00095	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00013	0.000935	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—POMC—polycystic ovary syndrome	0.000129	0.000927	CbGpPWpGaD
Mitotane—FDX1—Metabolism—LHB—polycystic ovary syndrome	0.000129	0.000924	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000129	0.000922	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—BCL2—polycystic ovary syndrome	0.000127	0.00091	CbGpPWpGaD
Mitotane—FDX1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000126	0.000903	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000126	0.000902	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000123	0.000881	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000122	0.000875	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000121	0.000869	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000119	0.000855	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000114	0.000816	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000113	0.000811	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000112	0.000805	CbGpPWpGaD
Mitotane—FDX1—Metabolism—RRM2—polycystic ovary syndrome	0.000109	0.00078	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—BCL2—polycystic ovary syndrome	0.000108	0.000778	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000108	0.000775	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000105	0.000754	CbGpPWpGaD
Mitotane—FDX1—Metabolism—YAP1—polycystic ovary syndrome	0.000105	0.000752	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000104	0.000743	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000103	0.000739	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000101	0.000723	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NAMPT—polycystic ovary syndrome	0.000101	0.000722	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.0001	0.000718	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP11A1—polycystic ovary syndrome	9.94e-05	0.000713	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—LPCAT2—polycystic ovary syndrome	9.88e-05	0.000709	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SUOX—polycystic ovary syndrome	9.88e-05	0.000709	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.87e-05	0.000708	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	9.75e-05	0.0007	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	9.66e-05	0.000694	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKR1C3—polycystic ovary syndrome	9.38e-05	0.000674	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP17A1—polycystic ovary syndrome	9.24e-05	0.000663	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NMNAT3—polycystic ovary syndrome	9.24e-05	0.000663	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ISYNA1—polycystic ovary syndrome	9.18e-05	0.000659	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—POMC—polycystic ovary syndrome	9.15e-05	0.000657	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	8.97e-05	0.000644	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	8.81e-05	0.000633	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	8.61e-05	0.000618	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—LPCAT2—polycystic ovary syndrome	8.45e-05	0.000606	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SUOX—polycystic ovary syndrome	8.45e-05	0.000606	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	8.38e-05	0.000601	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	8.34e-05	0.000599	CbGpPWpGaD
Mitotane—FDX1—Metabolism—TH—polycystic ovary syndrome	7.99e-05	0.000574	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	7.95e-05	0.000571	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ISYNA1—polycystic ovary syndrome	7.86e-05	0.000564	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—POMC—polycystic ovary syndrome	7.83e-05	0.000562	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TEAD2—polycystic ovary syndrome	7.81e-05	0.00056	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKR1C2—polycystic ovary syndrome	7.81e-05	0.00056	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SLC2A4—polycystic ovary syndrome	7.78e-05	0.000558	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	7.68e-05	0.000551	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	7.51e-05	0.000539	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	7.39e-05	0.00053	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP19A1—polycystic ovary syndrome	7.31e-05	0.000525	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	7.17e-05	0.000514	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKR1C2—polycystic ovary syndrome	6.68e-05	0.000479	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TEAD2—polycystic ovary syndrome	6.68e-05	0.000479	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PNPLA2—polycystic ovary syndrome	6.54e-05	0.00047	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GNAS—polycystic ovary syndrome	6.53e-05	0.000468	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	6.42e-05	0.000461	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	6.32e-05	0.000454	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NCOR1—polycystic ovary syndrome	6.22e-05	0.000446	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SRD5A1—polycystic ovary syndrome	6.2e-05	0.000445	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—STAR—polycystic ovary syndrome	5.92e-05	0.000425	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP1A1—polycystic ovary syndrome	5.89e-05	0.000423	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5.85e-05	0.00042	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PNPLA2—polycystic ovary syndrome	5.6e-05	0.000402	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MTHFR—polycystic ovary syndrome	5.49e-05	0.000394	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SRD5A1—polycystic ovary syndrome	5.31e-05	0.000381	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HMMR—polycystic ovary syndrome	5.27e-05	0.000378	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—STAR—polycystic ovary syndrome	5.06e-05	0.000363	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HSD3B1—polycystic ovary syndrome	5.03e-05	0.000361	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5e-05	0.000359	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.97e-05	0.000357	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.71e-05	0.000338	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—LHB—polycystic ovary syndrome	4.59e-05	0.000329	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HMMR—polycystic ovary syndrome	4.51e-05	0.000324	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HSD3B2—polycystic ovary syndrome	4.48e-05	0.000322	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPARG—polycystic ovary syndrome	4.46e-05	0.00032	CbGpPWpGaD
Mitotane—FDX1—Metabolism—POMC—polycystic ovary syndrome	4.39e-05	0.000315	CbGpPWpGaD
Mitotane—FDX1—Metabolism—INS—polycystic ovary syndrome	4.37e-05	0.000314	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKR1C1—polycystic ovary syndrome	4.34e-05	0.000312	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HSD3B1—polycystic ovary syndrome	4.3e-05	0.000309	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.25e-05	0.000305	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.03e-05	0.000289	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SULT2A1—polycystic ovary syndrome	4e-05	0.000287	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—LHB—polycystic ovary syndrome	3.93e-05	0.000282	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—RRM2—polycystic ovary syndrome	3.87e-05	0.000278	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HSD3B2—polycystic ovary syndrome	3.84e-05	0.000275	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—YAP1—polycystic ovary syndrome	3.73e-05	0.000268	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKR1C1—polycystic ovary syndrome	3.72e-05	0.000267	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NAMPT—polycystic ovary syndrome	3.58e-05	0.000257	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.56e-05	0.000256	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP11A1—polycystic ovary syndrome	3.54e-05	0.000254	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.52e-05	0.000252	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.42e-05	0.000245	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKR1C3—polycystic ovary syndrome	3.34e-05	0.00024	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—RRM2—polycystic ovary syndrome	3.31e-05	0.000238	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP17A1—polycystic ovary syndrome	3.29e-05	0.000236	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—YAP1—polycystic ovary syndrome	3.19e-05	0.000229	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NAMPT—polycystic ovary syndrome	3.07e-05	0.00022	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.05e-05	0.000219	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.01e-05	0.000216	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.86e-05	0.000205	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TH—polycystic ovary syndrome	2.85e-05	0.000204	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.82e-05	0.000202	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC2A4—polycystic ovary syndrome	2.77e-05	0.000199	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP19A1—polycystic ovary syndrome	2.6e-05	0.000187	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TH—polycystic ovary syndrome	2.44e-05	0.000175	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.37e-05	0.00017	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GNAS—polycystic ovary syndrome	2.32e-05	0.000167	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.23e-05	0.00016	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NCOR1—polycystic ovary syndrome	2.21e-05	0.000159	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1A1—polycystic ovary syndrome	2.1e-05	0.000151	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GNAS—polycystic ovary syndrome	1.99e-05	0.000143	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTHFR—polycystic ovary syndrome	1.96e-05	0.00014	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NCOR1—polycystic ovary syndrome	1.89e-05	0.000136	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.8e-05	0.000129	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTHFR—polycystic ovary syndrome	1.67e-05	0.00012	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPARG—polycystic ovary syndrome	1.59e-05	0.000114	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—POMC—polycystic ovary syndrome	1.57e-05	0.000112	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—INS—polycystic ovary syndrome	1.56e-05	0.000112	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPARG—polycystic ovary syndrome	1.36e-05	9.75e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—POMC—polycystic ovary syndrome	1.34e-05	9.61e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—INS—polycystic ovary syndrome	1.33e-05	9.56e-05	CbGpPWpGaD
